Hybio Pharmaceutical (300199) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.177x

Based on the latest financial reports, Hybio Pharmaceutical (300199) has a cash flow conversion efficiency ratio of 0.177x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.78 Million ≈ $17.23 Million USD) by net assets (CN¥666.08 Million ≈ $97.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Hybio Pharmaceutical fund operations to measure how many days the company can operate on defensive assets alone.

Hybio Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Hybio Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hybio Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hybio Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Colt CZ Group SE PR:CZG	0.099x
Tongyu Communication Inc SHE:002792	0.032x
Guangzhou Fangbang Electronics Co Ltd SHG:688020	0.018x
Centuri Holdings, Inc. NYSE:CTRI	-0.040x
Iljin Electric Co KO:103590	-0.143x
Steven Madden Ltd NASDAQ:SHOO	-0.058x
AIR FRANCE-KLM ADR EO 85 F:FQZ	0.525x
BW LPG Ltd OL:BWLPG	0.310x

Annual Cash Flow Conversion Efficiency for Hybio Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hybio Pharmaceutical from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300199 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥597.05 Million ≈ $87.37 Million	CN¥164.71 Million ≈ $24.10 Million	0.276x	+6209.36%
2023-12-31	CN¥783.21 Million ≈ $114.61 Million	CN¥-3.54 Million ≈ $-517.51K	-0.005x	-137.05%
2022-12-31	CN¥1.30 Billion ≈ $189.78 Million	CN¥15.81 Million ≈ $2.31 Million	0.012x	-87.19%
2021-12-31	CN¥1.65 Billion ≈ $241.15 Million	CN¥156.83 Million ≈ $22.95 Million	0.095x	+232.72%
2020-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥47.99 Million ≈ $7.02 Million	0.029x	-38.96%
2019-12-31	CN¥2.23 Billion ≈ $326.77 Million	CN¥104.64 Million ≈ $15.31 Million	0.047x	+238.15%
2018-12-31	CN¥3.39 Billion ≈ $496.31 Million	CN¥47.00 Million ≈ $6.88 Million	0.014x	-74.81%
2017-12-31	CN¥3.88 Billion ≈ $568.47 Million	CN¥213.74 Million ≈ $31.28 Million	0.055x	-33.09%
2016-12-31	CN¥3.60 Billion ≈ $527.46 Million	CN¥296.41 Million ≈ $43.37 Million	0.082x	+56.20%
2015-12-31	CN¥2.64 Billion ≈ $385.92 Million	CN¥138.84 Million ≈ $20.32 Million	0.053x	-55.53%
2014-12-31	CN¥1.30 Billion ≈ $189.67 Million	CN¥153.43 Million ≈ $22.45 Million	0.118x	-13.29%
2013-12-31	CN¥1.12 Billion ≈ $164.51 Million	CN¥153.48 Million ≈ $22.46 Million	0.137x	+59.09%
2012-12-31	CN¥1.02 Billion ≈ $148.68 Million	CN¥87.19 Million ≈ $12.76 Million	0.086x	+15.57%
2011-12-31	CN¥976.09 Million ≈ $142.83 Million	CN¥72.48 Million ≈ $10.61 Million	0.074x	-75.48%
2010-12-31	CN¥180.59 Million ≈ $26.43 Million	CN¥54.69 Million ≈ $8.00 Million	0.303x	+48.18%
2009-12-31	CN¥127.74 Million ≈ $18.69 Million	CN¥26.11 Million ≈ $3.82 Million	0.204x	-55.67%
2008-12-31	CN¥99.23 Million ≈ $14.52 Million	CN¥45.75 Million ≈ $6.69 Million	0.461x	-54.21%
2007-12-31	CN¥48.70 Million ≈ $7.13 Million	CN¥49.04 Million ≈ $7.18 Million	1.007x	--

About Hybio Pharmaceutical

SHE:300199 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.84 Billion

CN¥19.43 Billion CNY

Market Cap Rank

#5186 Global

#980 in China

Share Price

CN¥22.00

Change (1 day)

-0.59%

52-Week Range

CN¥16.18 - CN¥29.95

All Time High

CN¥29.95